Open Access
| Issue |
Vis Cancer Med
Volume 5, 2024
|
|
|---|---|---|
| Article Number | E2 | |
| Number of page(s) | 3 | |
| DOI | https://doi.org/10.1051/vcm/2024005 | |
| Published online | 06 May 2024 | |
- Qian CN, Zhang W, Xu RH. Defeating cancer: the 150 most important questions in cancer research and clinical oncology. Chin J Cancer. 2016;35(1):104. [CrossRef] [PubMed] [Google Scholar]
- Wee JT, Poh SS. The most important questions in cancer research and clinical oncology: Question 1. Could the vertical transmission of human papilloma virus (HPV) infection account for the cause, characteristics, and epidemiology of HPV-positive oropharyngeal carcinoma, non-smoking East Asian female lung adenocarcinoma, and/or East Asian triple-negative breast carcinoma? Chin J Cancer. 2017;36(1):13. [CrossRef] [PubMed] [Google Scholar]
- Venniyoor A. The most important questions in cancer research and clinical oncology-Question 2–5. Obesity-related cancers: more questions than answers. Chin J Cancer. 2017;36(1):18. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 6–14: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):33. [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 15–24: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):39. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: Questions 25–30: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):42. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 31–39: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):48. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 40–49. Chin J Cancer. 2017;36(1):55. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 50–56. Chin J Cancer. 2017;36(1):69. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 57–66: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):79. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 67–75: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):86. [CrossRef] [PubMed] [Google Scholar]
- Editorial Office of Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 76–85: Edited by Chinese Journal of Cancer. Chin J Cancer. 2017;36(1):91. [CrossRef] [PubMed] [Google Scholar]
- Chinese Journal of C. The 150 most important questions in cancer research and clinical oncology series: questions 86–93: Edited by Chinese Journal of Cancer. Chin J Cancer. 2018;37(1):1. [CrossRef] [PubMed] [Google Scholar]
- Cancer C. The 150 most important questions in cancer research and clinical oncology series: questions 94–101: Edited by Cancer Communications. Cancer Commun (Lond). 2018;38(1):69. [PubMed] [Google Scholar]
- Qian CN, Pezzella F, Lu Z. Revisiting and proposing the most important questions in cancer research and clinical oncology. Vis Cancer Med. 2024;5:E1. [CrossRef] [EDP Sciences] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.